ALBKY

ALBKY is in a Stage 2 uptrend with a bullish medium-term bias supported by rising EMAs and higher highs & lows. However, extreme overbought readings and a bullish exhaustion signal indicate near-term fatigue. Price is extended above the 9/20 EMAs without a corrective pullback, making current timing unfavorable. Execution should be deferred until a pullback into the rising EMA support zone to align with the Value + EPS accumulation strategy.

• ↑Profits climbed 44% YoY to €943 M in 2025, normalized ROTCE at 13.9%
• ↑Strong CET1 ratio of 15.7% supports a €519 M distribution plan
• ↓Negative earnings yield and weak profitability factor suggest overvaluation